Introducing COVID-19 Whole Genome Sequencing service

We are now offering a Whole Genome Sequencing service to support SARS-CoV-2 testing laboratories, enabling them to provide Day 2 testing for 'Test to Release' in the UK.

March 8, 2021

Introducing Whole Genome Sequencing service to support SARS-CoV-2 testing laboratories.

Government regulations, recently announced, set out the minimum standards that private sector providers must meet for SARS-CoV-2 tests for people arriving in England.

All international arrivals to the UK are required to take a test on day 2 and day 8 of their quarantine period for variant surveillance.

Day 2 samples shown to be positive from qRT-PCR testing will have the SARS-CoV-2  genomes sequenced to look for novel variants.

automated testing service

Advances in viral surveillance with Whole Genome Sequencing

We are now offering a Whole Genome Sequencing service to support SARS-CoV-2 testing laboratories, enabling them to provide Day 2 testing for 'Test to Release' in the UK.

During the pandemic, we have expanded our accredited service facility to support a complete SARS-CoV-2 testing workflow. We've now developed a novel and highly rapid Whole Genome Sequencing (WGS) library preparation approach for sequencing viral genomes with nanopore sequencing.

Whole genome sequencing increases our understanding of the changes in the viral genome that will allow public health institutions to monitor the development and spread of the epidemic, guide control measures and inform vaccine research. Assay development for the new service was funded by a grant from Innovate UK, the UK’s innovation agency.

 

Chris Sale, CEO of Nonacus, said: “We are proud to have developed this clinical service and support the government’s test-to-release scheme. Our method will provide a faster, lower cost offering for Whole Genome Viral Sequencing, which will be key in identifying and monitoring variants. We look forward to supporting laboratories undertaking SARS-CoV-2 testing, as well as aiding public health institutions in their surveillance of the virus.”

Learn more

automated testing service

SARS-CoV-2 testing services

Viral RNA extraction, qRT-PCR and rapid whole genome sequencing (WGS) workflows for detection of all known variants of SARS-CoV-2.

sars-cov-2-products

SARS-CoV-2 testing products

The VirPath product range covers the complete testing workflow from RNA extraction to highly sensitive and accurate multiplex qRT-PCR.

service-facility

Accredited service facility

Our accredited service facility, based in Birmingham, UK, offers service support for the whole range of Nonacus panels.

Test-for-release-covid

Viral Surveillance

Nonacus was awarded an Innovate UK grant, to validate a novel, rapid method for sequencing respiratory viral genomes using nanopore sequencing.